Premium
What is new in beta‐lactam allergy in children?
Author(s) -
AtanaskovicMarkovic Marina
Publication year - 2021
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.13375
Subject(s) - medicine , allergy , beta lactam , drug allergy , antibiotics , intensive care medicine , pediatrics , broad spectrum , population , dermatology , immunology , chemistry , environmental health , microbiology and biotechnology , combinatorial chemistry , biology
This review highlights the novelties in understanding the underlying immunologic mechanisms of drug hypersensitivity reactions (DHRs) with special reference to beta‐lactams (BLs) in the pediatric population, as well as tiny changes in clinical classification and diagnosis of DHRs, in the last couple of years. BLs are still the most commonly prescribed and used antibiotics in children. Viral infections are very often in children, and they can provoke skin rashes which are difficult to differentiate from DHRs. The majority of children are incorrectly labeled as “allergic.” Therefore, allergy to BLs in children is overdiagnosed. These children often receive suboptimal treatment with second‐line broad‐spectrum antibiotics, which are less effective, more costly, and associated with an increased risk of antibiotic‐resistant infections. This prolongs hospitalization and thus more uses health care. The correct diagnosis of BL allergy in children is still an important and hot topic. This review has outlined the need for correct diagnosis of BL allergy in children and all the controversies encountered by pediatricians and pediatric allergists. It is also necessary to change the paradigm.